M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer

Clinical trial NCT03579472 · TERMINATED

Trial details

NCT number: NCT03579472
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Triple-Negative Breast Carcinoma Prognostic Stage IV Breast Cancer AJCC v8

Start date: 2018-05-30
Primary completion: 2022-09-21
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.